Taste evaluation of a novel midazolam tablet for pediatric patients: In vitro drug dissolution, in vivo animal taste aversion and clinical taste perception profiles
dc.contributor.author | Cheung, Laurence | |
dc.contributor.author | Nguyen, M. | |
dc.contributor.author | Tang, E. | |
dc.contributor.author | von Ungern Sternberg, B. | |
dc.contributor.author | Salman, S. | |
dc.contributor.author | Tuleu, C. | |
dc.contributor.author | Mohamed Ahmed, A. | |
dc.contributor.author | Soto, J. | |
dc.contributor.author | Lim, L. | |
dc.date.accessioned | 2018-05-18T08:00:24Z | |
dc.date.available | 2018-05-18T08:00:24Z | |
dc.date.created | 2018-05-18T00:22:54Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Cheung, L. and Nguyen, M. and Tang, E. and von Ungern Sternberg, B. and Salman, S. and Tuleu, C. and Mohamed Ahmed, A. et al. 2018. Taste evaluation of a novel midazolam tablet for pediatric patients: In vitro drug dissolution, in vivo animal taste aversion and clinical taste perception profiles. International Journal of Pharmaceutics. 535 (1-2): pp. 194-200. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/67975 | |
dc.identifier.doi | 10.1016/j.ijpharm.2017.10.060 | |
dc.description.abstract |
© 2017 Elsevier B.V. Harmonized methodologies are urgently required for the taste evaluation of novel pediatric medicines. This study utilized in vitro, in vivo and clinical data to evaluate the palatability of a novel midazolam chocolate tablet. In vitro dissolution experiments showed the crushed tablet to release within 5 min 1.68 mg of midazolam into simulated saliva. This translated to a drug level of 0.84 mg/ml in the oral cavity, which would be higher than the midazolam bitterness detection threshold concentration of 0.03 mg/ml determined in a rat ‘brief access taste aversion’ (BATA) model. The visual analogue scale scores of patients aged 4–16 years prescribed with midazolam pre-surgery showed a clear preference for the midazolam chocolate tablets (3.35 ± 1.04, n = 20) compared to the control midazolam solution (1.47 ± 0.62, n = 17). The clinical data was in agreement with the in vivo rodent data in showing the novel chocolate tablet matrix to be effective at taste-masking the bitter midazolam. | |
dc.publisher | Elsevier BV | |
dc.title | Taste evaluation of a novel midazolam tablet for pediatric patients: In vitro drug dissolution, in vivo animal taste aversion and clinical taste perception profiles | |
dc.type | Journal Article | |
dcterms.source.volume | 535 | |
dcterms.source.number | 1-2 | |
dcterms.source.startPage | 194 | |
dcterms.source.endPage | 200 | |
dcterms.source.issn | 0378-5173 | |
dcterms.source.title | International Journal of Pharmaceutics | |
curtin.department | School of Pharmacy and Biomedical Sciences | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |